Investigation of hypertension and the recognition of monogenic hypertension

Archives of Disease in Childhood

Volumn 81, Issue 5, 1999, Pages 452-455

  Milford, David V ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BICARBONATE; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; MINERALOCORTICOID; POTASSIUM ION; RENIN; SODIUM ION;

ARTICLE; BLOOD PRESSURE REGULATION; CONGENITAL ADRENAL HYPERPLASIA; GENETIC SUSCEPTIBILITY; GORDON SYNDROME; HORMONAL REGULATION; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BALANCE; SYNDROME DELINEATION;

EID: 0032754060     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.81.5.452     Document Type: Article

References (27)

1. Andre JL, Deschamps JP, Gueguen R. La tension arterielle chez l'enfant et l'adolescent: valeurs rapportees a l'age et a la taille chez 17, 067 sûjets. Arch Fr Pediatr 1980;37:477-82.
2. Elises JS, Griffiths PD, Hocking MD, Taylor CM, White RHR. Simplified quantification of urinary protein excretion in children. Clin Nephrol 1988;30:225-9.
3. Honour JW, Dillon MJ, Levin M, Shah V. Fatal, low renin hypertension associated with a disturbance of cortisol metabolism. Arch Dis Child 1983;58:1018-20.
4. Batista MC, Mendonca BB, Kater CE, et al. Spironolactone-reversible rickets associated with 11β-hydroxysteroid dehydrogenase deficiency syndrome. J Pediatr 1986;109:989-93.
5. Milford DV, Shackleton CHL, Stewart PM. Mineralocorticoid hypertension and congenital deficiency of 11β-hydroxysteroid dehydrogenase in a family with the syndrome of "apparent" mineralocorticoid excess. Clin Endocrinol 1994;43:241-6.
6. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW. Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 1988;82:340-9.
7. Stewart PM, Murray BA, Mason JI. Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependant enzyme and differs from the cloned type I isoform. J Clin Endocrinol Metab 1994;79:480-4.
8. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet 1995;10:393-9.
9. Stewart PM, Edwards CRW. The cortisol cortisone shuttle and hypertension. J Steroid Biochem Mol Biol 1991;40:501-9.
10. Walker BR, Stewart PM, Shackleton CHL, Padfield PL, Edwards CRW. Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol 1993;39:221-7.
11. Stewart PM, Rogerson FM, Mason JI. Type 2 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 1995;80:885-90.
12. Rich GM, Ulick S, Cook S, Wang JZ, Lifton RP, Dluhy RG. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med 1992;116:813-20.
13. Dluhy RG, Lifton RP. Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 1995;60:48-51.
14. Litchfield WR, Coolidge C, Silva P, et al. Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1997;82:1507-10.
15. Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992;355:262-5.
16. Lifton RP, Dluhy RG, Powers M, et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 1992;2:66-74.
17. Gates LJ, MacConnachie AA, Lifton RP, Haites NE, Benjamin N. Variation of phenotype in patients with glucocorticoid remediable aldosteronism. J Med Genet 1996;33:25-8.
18. Chua SC, Szabo P, Vitek A, Grzeschik KH, John M, White PC. Cloning of cDNA encoding steroid 11-beta-hydroxylase (P450C11). Proc Natl Acad Sci USA 1987;84:7193-7.
19. Fan YS, Sasi R, Lee C, Winter JSD, Waterman MR, Lin CC. Localisation of the human CYP17 gene (cytochrome P450-17-alpha) to 10q24.3 by fluorescence in situ hybridization and simultaneous chromosome banding. Genomics 1992;14:1110-11.
20. Liddle GW, Bledsoe T, Coppage WS. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Phys 1963;76:199-213.
21. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994;79:407-14.
22. Hansson JH, Nelson-Williams C, Suzuki H, et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 1995;11:76-82.
23. Findling JW, Raff H, Hansson JH, Lifton RP. Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab 1997;82:1071-4.
24. Gordon RD, Geddes RA, Pawsey GK, O'Halloran MW. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australian Annals of Medicine 1970;4:287-94.
25. Rodriguez-Soriano J, Vallo A. Renal tubular hyperkalaemia in childhood. Pediatr Nephrol 1988;2:498-509.
26. Mansfield TA, Simon DB, Farfel Z, et al. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 1997;16:202-5.
27. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.